-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Pp8SHMmoWyca9zJWPgwLk/CzZL1lqeW6YrCR37ksELWtZ3NO0B85MfELqMexIoua IcapHtzQ01eW1VtZ8aP4sA== 0001235802-04-000170.txt : 20041012 0001235802-04-000170.hdr.sgml : 20041012 20041012175010 ACCESSION NUMBER: 0001235802-04-000170 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041008 FILED AS OF DATE: 20041012 DATE AS OF CHANGE: 20041012 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 582301143 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 BARCLAY BLVD STE 280 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 MAIL ADDRESS: STREET 1: 111 BARCLAY BLVD STE 280 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELL STEVEN J CENTRAL INDEX KEY: 0001241292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 041075769 BUSINESS ADDRESS: STREET 1: 4600 HIGHLANDS PARKWAY STREET 2: SUITE A & B CITY: SMYRNA STATE: GA ZIP: 30082 BUSINESS PHONE: 7708059769 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2004-10-08 0 0001023024 BIOSANTE PHARMACEUTICALS INC bpa 0001241292 BELL STEVEN J 111 BARCLAY BOULEVARD LINCOLNSHIRE IL 60069 0 1 0 0 VP Research & Clin. Develop. Common Stock 2004-10-08 4 M 0 12500 2.85 A 13875 D Common Stock 2004-10-08 4 S 0 2500 9.81 D 11375 D Common Stock 2004-10-08 4 S 0 2000 9.8 D 9375 D Common Stock 2004-10-12 4 S 0 2500 9.85 D 6875 D Employee Stock Option (right to buy) 2.85 2004-10-08 4 M 0 12500 2.85 D 2006-10-27 Common Stock 12500 0 D This Form 4 report has also been amended to reflect Mr. Bell's current beneficial ownerhsip of 1,375 shares before this option exercise instead of 12,375 shares as previously reported incorrectly on his January 21, 2004 Form 4 report. This option vests upon the attainment of certain milestones under Mr. Bell's employment agreement. /s/ Steven J. Bell, Ph.D.,by Phillip B. Donenberg, attorney-in-fact 2004-10-12 -----END PRIVACY-ENHANCED MESSAGE-----